Semigran Marc
- SEC CIK
- 0001691494
No open-market purchases or sales filed in the past year.
Current role at each company
- EWTX Edgewise Therapeutics, Inc.Chief Development Officeras of Dec 27, 2024
- RCOR Renovacor, Inc.Chief Medical Officeras of Dec 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Semigran Marc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EWTX Edgewise Therapeutics, Inc.
Chief Development Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2024 (view filing) | Dec 24 | 3 days | Semigran MarcChief Development Officer | SSale | −29.7K | $29.68 | −$881.9K | −81.6%6.72K after | 2 lots10b5-1 |